E2F8 transcription factor is involved in cell angiogenesis and polyploidization, and epidemiological analysis has shown that E2F8 levels are elevated in metastatic prostate cancer, which is associated with poor prognosis. Here, E2F8 is linked to metastatic prostate carcinoma.